Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-release vs Sublingual Buprenorphine in Individuals Leaving Jail
NCT06306443Phase 3Recruiting
- Sponsor
- Friends Research Institute
- Start
- Jun 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by Friends Research Institute. Started Jun 2025; status: recruiting.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06306443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306443.